Drugs / Lubristil
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1/2 | NCT03084861 Background | Feb 2017 → Mar 2020 | neurotrophic keratopathy | Blood and Tissue Bank of Catalonia | Terminated | No outcome recorded Stop: Enrollment |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Lubristil | “Artificial tears: Lubristil ®” NCT03084861 ↗ |
| Route | Other | “Route of administration: ophthalmic” NCT03084861 ↗ |